切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2019, Vol. 07 ›› Issue (03) : 251 -254. doi: 10.3877/cma.j.issn.2095-5782.2019.03.016

所属专题: 文献

综述

布加综合征的介入治疗研究进展
史青苗1, 袁新1, 李娟1, 余祖江1,()   
  1. 1. 450052 河南郑州,郑州大学第一附属医院感染科
  • 收稿日期:2019-04-09 出版日期:2019-08-01
  • 通信作者: 余祖江
  • 基金资助:
    国家自然科学基金青年科学基金项目(81702927)

Research progress in interventional therapy for treatment of Budd-Chiari syndrome

Qingmiao Shi1, Xin Yuan1, Juan Li1, Zujiang Yu1,()   

  1. 1. Department of Infection Disease, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Received:2019-04-09 Published:2019-08-01
  • Corresponding author: Zujiang Yu
  • About author:
    Corresponding author: Yu Zujiang, Email:
引用本文:

史青苗, 袁新, 李娟, 余祖江. 布加综合征的介入治疗研究进展[J/OL]. 中华介入放射学电子杂志, 2019, 07(03): 251-254.

Qingmiao Shi, Xin Yuan, Juan Li, Zujiang Yu. Research progress in interventional therapy for treatment of Budd-Chiari syndrome[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2019, 07(03): 251-254.

布加综合征是一种罕见的多病因疾病,临床表现可无症状、慢性或暴发性,其治疗应根据患者的病情采取逐步治疗策略。近年来,血管腔内介入治疗技术得到快速发展,依靠其安全、微创等优势,已成为布加综合征的首选治疗方式,其中,经皮腔内血管成形术、血管内支架植入术和经颈静脉肝内门体分流术在布加综合征的治疗中发挥重要价值。文章主要围绕布加综合征的介入治疗研究进展进行综述。

Budd-Chiari syndrome (BCS) is an infrequent disease with multiple causes. Its clinical manifestations could be asymptomatic, chronic or fulminant. The treatment strategy for BCS should be taken step by step basing on the patient's condition. In recent years, endovascular interventional therapy technology has developed rapidly, relying on its advantages such as safe and minimally invasive, it has became the first treatment choice for BCS. Among them, percutaneous transluminal angioplasty (PTA) and endovascular stent implantation (ESI) and transjugular intrahepatic portosystemic shunt (TIPS) gradually play an important role in the treatment for BCS. This article will review the research progress of interventional therapy for BCS.

[1]
Martens P, Nevens F. Budd-Chiari syndrome[J]. United European Gastroenterol J,2015,3(6): 489-500.
[2]
Bansal V, Gupta P, Sinha S,et al. Budd-Chiari syndrome: imaging review[J]. Br J Radiol,2018,91(1092): 20180441.
[3]
Eapen CE, Velissaris D, Heydtmann M,et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome[J]. Gut,2006,55(6): 878-884.
[4]
Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction[J]. Hepatol Int,2018,12(Suppl 1): 168-180.
[5]
马秀现,叶学祥,冯留顺,等.球囊扩张血管成形治疗布-加综合征[J].普外临床,1996,11(6): 339-340,324.
[6]
Cui YF, Fu YF, Li DC,et al. Percutaneous recanalization for hepatic vein-type Budd-Chiari syndrome: long-term patency and survival[J]. Hepatol Int,2016,10(2): 363-369.
[7]
项军,朱耀青,王岩,等.不同球囊导管治疗下腔静脉阻塞的回顾性分析[J].徐州医学院学报,2004,24(1): 22-25.
[8]
Ding PX, Zhang SJ, Li Z,et al. Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome[J]. J Gastroenterol Hepatol,2016,31(1): 222-228.
[9]
张文耀,许伟,徐浩,等.大球囊扩张治疗肝静脉阻塞型布-加综合征临床研究[J].介入放射学杂志,2018,27(10): 932-935.
[10]
韩新巍,丁鹏绪,吴刚.布加综合征下腔静脉阻塞直径30mm大球囊扩张的可行性研究[J].介入放射学杂志,2008,17(4): 243-246.
[11]
Han GH, Qi XS, Zhang W,et al. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center[J]. Radiology,2013,266(2): 657-667.
[12]
祖茂衡,张庆桥,顾玉明,等.血管内支架在布-加综合征远期疗效再评价[J].当代医学(中国介入放射学),2008(3):206-208.
[13]
Sonavane AD, Amarapurkar DN, Rathod KR,et al. Long term survival of patients undergoing TIPS in budd-chiari syndrome[J]. J Clin Exp Hepatol,2019,9(1): 56-61.
[14]
Hidaka M, Eguchi S. Budd-Chiari syndrome: Focus on surgical treatment[J]. Hepatol Res,2017,47(2): 142-148.
[15]
Garcia-Pagán JC, Heydtmann M, Raffa S,et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients[J]. Gastroenterology,2008,135(3): 808-815.
[16]
He FL, Wang L, Zhao HW,et al. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome[J]. World J Gastroenterol,2015,21(8): 2413-2418.
[17]
Fitsiori K, Tsitskari M, Kelekis A,et al. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center[J]. Cardiovasc Intervent Radiol,2014,37(3): 691-697.
[18]
顾玉明,祖茂衡,徐浩,等. 500例Budd-Chiari综合征介入治疗并发症分析[J].中华放射学杂志,2003,37(12): 1083-1086.
[19]
宋文,汪名权,张德志,等.布加综合征介入治疗中并发心包填塞、下腔静脉破裂规避策略[J].肝胆外科杂志,2016,24(4): 270-272.
[20]
祖茂衡,徐浩,顾玉明,等.布加综合征疑难病例与介入治疗相关并发症的处理(附1859例报道)[J].中国普外基础与临床杂志,2014,21(12): 1487-1494.
[21]
陈汉威,黄晨,黄益,等.静脉微创介入治疗进展[J].中华介入放射学电子杂志,2017,5(2): 61-64.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 叶美妮, 刘思嘉, 臧玉玮, 刘云建. 肝硬化门静脉血栓形成的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 379-384.
[3] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[4] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[5] 李佳伟, 庞建智, 闫鹏宇, 卫阳兵, 杨晓峰. 术中输尿管识别技术研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 520-524.
[6] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[7] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[8] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[13] 孙明策, 韩世焕. 海藻酸盐水凝胶支架在颅骨缺损修复中的应用进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 310-314.
[14] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[15] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?